Table: Torii Pharmaceutical - 6-MTH parent results
Jul 29 (Reuters)-
Torii Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Jun 30, 2022 Jun 30, 2021 Dec 31, 2022
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 23.10 21.56 49.80
(+8.5 pct)
Operating 2.68 1.79 6.20
(+50.0 pct) (-34.7 pct) (+33.2 pct)
Recurring 2.47 1.85 6.10
(+33.3 pct) (-36.2 pct) (+25.8 pct)
Net 1.85 1.24 4.40
(+48.3 pct) (-30.9 pct) (+30.4 pct)
EPS 65.69 yen 44.30 yen 156.61 yen
Ann Div 48.00 yen 48.00 yen
-Q2 div 24.00 yen 24.00 yen
-Q4 div 24.00 yen 24.00 yen
NOTE - Torii Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4551.T
Recent news on Torii Pharmaceutical Co
See all newsTable: Torii Pharmaceutical - 6-MTH parent results
Brief: Torii Pharmaceutical Co Ltd Says It Will Retire Treasury Shares Worth 2.39% Of Outstanding Stock On Aug 29
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Drugmaker Shionogi to buy Japan Tobacco's unit Torii Pharmaceutical for $1 billion (updated)